Nyah Shah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nyah Shah has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Katz
Department of Medicine McGill University Montreal Quebec Canada
1 shared publication - Arati Sharma
Department of Molecular and Precision Medicine (SC, AS), Department of Pediatrics (SD), Center for Cannabis and Natural Product Pharmaceuticals (CCNPP) (AS), Penn State Cancer Institute, Pennsylvania State University College of Medicine
1 shared publication - Carly Burow
Faculty of Science McMaster University Hamilton Ontario Canada
1 shared publication Celina Pasquale
Faculty of Medicine, l’Université de Montreal, Montréal, Canada
1 shared publication- David F. Claxton
Division of Hematology and Oncology, Department of Medicine, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA
1 shared publication - Fariha Chowdhury
Faculty of Science McMaster University Hamilton Ontario Canada
1 shared publication
Latest Publications
- Open Access
From Deworming to Cancer Therapy: Benzimidazoles in Hematological Malignancies
Drug repurposing is a strategy to discover new therapeutic uses for existing drugs, which have well-established toxicity profiles and are often more affordable. This approach has gained significant attention in recent years due to the high costs and low success rates associated with traditional drug development. Drug repositioning offers a more time- and cost-effective path for identifying new treatments. Several FDA-approved non-chemotherapy drugs have been investigated for their anticancer potential. Among these, anthelmintic benzimidazoles (such as albendazole, mebendazole, and flubendazole) have garnered interest due to their effects on microtubules and oncogenic signaling pathways. Blood cancers, which frequently develop resistance and have high mortality rates, present a critical need for effective therapies. This review highlights the recent advances in repurposing benzimidazoles for blood malignancies. These compounds induce cell cycle arrest, differentiation, tubulin depolymerization, loss of heterozygosity, proteasomal degradation, and inhibit oncogenic signaling to exert their anticancer effects. We also discuss current limitations and strategies to overcome them, emphasizing the potential of combining benzimidazoles with standard therapies for improved treatment of hematological cancers.
Open AccessFrom Deworming to Cancer Therapy: Benzimidazoles in Hematological Malignancies
Drug repurposing is a strategy to discover new therapeutic uses for existing drugs, which have well-established toxicity profiles and are often more affordable. This approach has gained significant attention in recent years due to the high costs and low success rates associated with traditional drug development. Drug repositioning offers a more time- and cost-effective path for identifying new treatments. Several FDA-approved non-chemotherapy drugs have been investigated for their anticancer potential. Among these, anthelmintic benzimidazoles (such as albendazole, mebendazole, and flubendazole) have garnered interest due to their effects on microtubules and oncogenic signaling pathways. Blood cancers, which frequently develop resistance and have high mortality rates, present a critical need for effective therapies. This review highlights the recent advances in repurposing benzimidazoles for blood malignancies. These compounds induce cell cycle arrest, differentiation, tubulin depolymerization, loss of heterozygosity, proteasomal degradation, and inhibit oncogenic signaling to exert their anticancer effects. We also discuss current limitations and strategies to overcome them, emphasizing the potential of combining benzimidazoles with standard therapies for improved treatment of hematological cancers.
- Open Access
- 6 September 2023
- Published by Public Library of Science (PLoS) in PLOS Climate
- Vol. 2 (9) , e0000202
Considerations for occupational heat exposure: A scoping review
The ability to regulate core body temperature is a critical factor in avoiding occupational heart stress in demanding environments. Heat-related illness in an occupational setting is complex and multifactorial and includes environment (intrinsic and extrinsic), the occupational clothing requirements and physiological factors. Much of this research began in the gold mines in South Africa after several miners died due to heat related illness. Similar research was conducted during World War Two and was crucial for the creation of acclimatization techniques and strategies for acquiring thermal tolerance. Techniques such as fatigue recovery and body cooling are still used today to prevent heat related illness in individuals with occupations that have frequent exposure to heat and high physical loads. These individuals are at greater risk of heat related illness as extended exposure to a hot or humid environment in combination with strenuous physical activity can overwhelm the body’s homeostatic cooling mechanisms. In addition, individuals from special populations with chronic or acute health impacts such as diabetes mellitus, also have a greater risk for the aforementioned. Currently, there are several heat prevention strategies, including training and education, regulation and monitoring, in place to protect workers from heat related illness and casualty. These strategies, along with future considerations and the impact of climate change will be highlighted in this review.
- 6 September 2023
- Published by Public Library of Science (PLoS) in PLOS Climate
- Vol. 2 (9) , e0000202
Open AccessConsiderations for occupational heat exposure: A scoping review
The ability to regulate core body temperature is a critical factor in avoiding occupational heart stress in demanding environments. Heat-related illness in an occupational setting is complex and multifactorial and includes environment (intrinsic and extrinsic), the occupational clothing requirements and physiological factors. Much of this research began in the gold mines in South Africa after several miners died due to heat related illness. Similar research was conducted during World War Two and was crucial for the creation of acclimatization techniques and strategies for acquiring thermal tolerance. Techniques such as fatigue recovery and body cooling are still used today to prevent heat related illness in individuals with occupations that have frequent exposure to heat and high physical loads. These individuals are at greater risk of heat related illness as extended exposure to a hot or humid environment in combination with strenuous physical activity can overwhelm the body’s homeostatic cooling mechanisms. In addition, individuals from special populations with chronic or acute health impacts such as diabetes mellitus, also have a greater risk for the aforementioned. Currently, there are several heat prevention strategies, including training and education, regulation and monitoring, in place to protect workers from heat related illness and casualty. These strategies, along with future considerations and the impact of climate change will be highlighted in this review.